Regenerative medicine for back pain can feel confusing. Some clinics promise miracle results from a single injection, while others dismiss biologic treatments as experimental or overhyped. In this episode, we take an evidence-first look at what the science actually says about PRP, stem cells, and regenerative spine care.

We start with platelet-rich plasma, or PRP — a biologic treatment made from your own blood. PRP is created by drawing a small blood sample, spinning it in a centrifuge, and concentrating the platelet-rich layer. These platelets contain growth factors and signaling proteins that may help support tissue repair, inflammation control, collagen production, and healing responses.

This episode explains why PRP may be relevant for carefully selected patients with chronic discogenic low back pain, including pain believed to come from the spinal disc itself. We also discuss intradiscal PRP, epidural PRP for lumbar disc herniation with radiculopathy, and why PRP works on a different timeline than a steroid injection. Unlike steroids, which often provide short-term inflammation relief, PRP is intended to support a slower biologic healing response over weeks to months.

We also take a balanced look at stem cell therapy for spine conditions. Stem cell research is promising, but current marketing often runs ahead of the evidence. You’ll learn why PRP currently has a stronger evidence base in selected spine cases, why patient selection matters, and why regenerative treatments are most likely to help when there is still enough healthy tissue biology left to respond.

At Vertrae® in Dayton, Ohio, Dr. Kamal Woods uses an evidence-first, MotionFirst™ approach to evaluate whether regenerative spine care, conservative treatment, interventional pain management, minimally invasive spine surgery, or another targeted option is most appropriate for each patient.

No hype. No blanket dismissal. Just a clear conversation about what regenerative medicine may support, where the evidence is still emerging, and who may be the right candidate.

Visit Vertrae.com to request your MotionFirst™ evaluation.

If you are still living with burning, shooting, or localized nerve pain after surgery, this episode explains why the pain may continue even after the original tissue has healed.

We explore how chronic post-surgical nerve pain can develop when the nervous system remains stuck in an alarm state, especially when pain is concentrated in a specific area of the body. This type of pain may not always show up clearly on traditional imaging because the issue is not always a structural problem — it may be a nerve signaling problem.

In this episode, you’ll learn how the dorsal root ganglion, or DRG, acts as a regional hub for sensory signals, and why it can become hypersensitive after procedures such as hernia repair, joint surgery, spine surgery, or other operations. We also explain how DRG stimulation differs from traditional spinal cord stimulation by targeting the specific nerve cluster responsible for pain in one localized region.

You’ll also hear what patients can expect from the temporary DRG stimulation trial, why the trial phase matters before considering a permanent implant, and how specialists evaluate whether this therapy may be appropriate.

At Vertrae® in Dayton, Ohio, Dr. Kamal Woods evaluates patients with chronic surgical pain, localized nerve pain, CRPS, and other focal pain conditions to determine whether DRG stimulation may be an option.

Visit Vertrae.com to learn more or request a MotionFirst™ evaluation.

If your pain is severe, localized, burning, or electric — but your scans keep coming back “normal” — this episode is for you.

We explore why chronic localized nerve pain, including complex regional pain syndrome, or CRPS, may not show up clearly on traditional imaging. Instead of coming from a visible structural problem, this type of pain can come from a processing error in the nervous system, specifically within the dorsal root ganglion, or DRG.

You’ll learn how the DRG acts like a regional signal hub for sensation, why it can become hypersensitive after an injury or surgery, and how that can lead to pain, skin sensitivity, color changes, temperature changes, swelling, or burning sensations in one specific area of the body.

This episode also explains how DRG stimulation differs from traditional spinal cord stimulation, why it may be a more targeted option for focal nerve pain, and what patients can expect from the temporary trial phase before considering a permanent implant.

At Vertrae® in Dayton, Ohio, Dr. Kamal Woods evaluates patients with chronic localized nerve pain, CRPS, and post-surgical nerve pain to determine whether DRG stimulation may be appropriate.

Visit Vertrae.com to learn more or request a MotionFirst™ evaluation.

What happens when pain stays trapped in one specific area long after the original injury has healed?

In this episode, we explore dorsal root ganglion stimulation, or DRG-S, a highly targeted neuromodulation therapy designed for certain types of chronic localized nerve pain, including complex regional pain syndrome, or CRPS. Unlike pain caused by a visible structural injury on imaging, localized nerve pain can come from a processing error in the nervous system itself — specifically within the dorsal root ganglion, the sensory “mailroom” that helps process pain signals from a specific region of the body.

We break down why traditional imaging may look normal even when pain is severe, how CRPS can cause burning pain, color changes, temperature differences, swelling, and extreme sensitivity to touch, and how clinicians use tools like the Budapest criteria to evaluate this condition. You’ll also learn how DRG stimulation differs from traditional spinal cord stimulation, why it may be more precise for focal pain, and what patients can expect from the trial phase before considering a permanent implant.

This conversation also covers the ACCURATE trial, long-term outcomes, possible limitations, lead migration, insurance considerations, and why careful patient selection matters. For patients with pain that burns, shoots, or stays locked in one specific area after an injury or surgery, DRG-S may offer a more targeted path worth discussing with a specialist.

At Vertrae® in Dayton, Ohio, Dr. Kamal Woods personally evaluates candidates for DRG stimulation. When appropriate, DRG-S trials and implants are performed at Vertrae® Surgery Center in Miamisburg, a spine-exclusive outpatient facility.

Visit Vertrae.com to request a MotionFirst™ evaluation.

If your MRI looked “normal,” surgery was not recommended, and physical therapy did not give you lasting relief, why does your back still hurt?

In this episode, we explore a missing piece in chronic mechanical low back pain: the multifidus muscle. The multifidus is a deep spinal stabilizing muscle that helps control small movements of the lumbar spine. After a back injury, disc irritation, or spinal pain episode, the nervous system can reflexively shut this muscle down through a process called arthrogenic muscle inhibition. For some patients, that signal does not fully turn back on — even after the original injury has healed.

This conversation breaks down why chronic back pain is not always explained by MRI findings, why “mild degenerative changes” may not tell the whole story, and why years of physical therapy may not fully resolve pain when the multifidus muscle is inhibited at the spinal cord level. You’ll also learn how restorative neurostimulation with ReActiv8® is designed to directly stimulate the motor nerve connected to the multifidus, helping restore neuromuscular control over time.

We discuss who ReActiv8® may be designed for, how it differs from spinal cord stimulation, what the outpatient implant procedure involves, and how a simple in-office prone instability test may help identify whether multifidus dysfunction is contributing to chronic mechanical low back pain.

At Vertrae® in Dayton, Ohio, Dr. Kamal Woods, MD, MBA personally evaluates patients to determine whether ReActiv8® may be appropriate based on their pain pattern, history, prior treatments, and clinical exam findings.

Listen to learn why your pain may not be a failure of effort — and how the right evaluation may uncover a mechanism that standard imaging can miss.

Visit Vertrae.com to learn more or request an evaluation.

In this episode, we explore ReActiv8®, a reversible spinal implant designed to address chronic mechanical low back pain linked to multifidus muscle dysfunction. Instead of masking pain signals, ReActiv8® uses restorative neurostimulation to help reactivate deep stabilizing muscles in the lower back over time.

You’ll learn who ReActiv8® is designed for, how it differs from spinal cord stimulation or fusion surgery, what the outpatient implant process involves, and why recovery requires patience, daily therapy, and a long-term view. We also discuss the emotional toll of chronic back pain, physical therapy frustration, and how clinical evaluation can help determine whether multifidus dysfunction may be contributing to spinal instability.

Chronic mechanical low back pain can feel like a cycle you cannot escape, especially after years of failed injections, medications, physical therapy, and unanswered questions. In this episode, we take a clear, compassionate look at ReActiv8®, a restorative neurostimulation treatment designed for a very specific type of chronic low back pain linked to multifidus muscle dysfunction.

This conversation breaks down how mechanical, central low back pain differs from sciatica, herniated disc pain, and other structural spine problems. You’ll learn why the multifidus muscles matter for spinal stability, how arthrogenic muscle inhibition can “shut down” key stabilizing muscles, and why some patients may continue to struggle even after dedicated physical therapy.

We also explore what the ReActiv8® treatment process actually involves, including outpatient implantation, the two-week waiting period before activation, twice-daily therapy sessions, and the months-long timeline often required for meaningful improvement. The episode also discusses important candidacy factors, reversibility, clinical evaluation, and the role of the prone instability test in identifying patients who may benefit from motor nerve stimulation.

For anyone living with long-term localized low back pain, this episode offers an honest, data-informed look at the difference between masking pain and addressing a possible root cause of spinal instability.

Why does chronic low back pain sometimes continue for years, even after physical therapy, injections, medications, and reassuring imaging?

In this episode, we take a deep dive into a lesser-known cause of chronic mechanical low back pain: multifidus dysfunction. The multifidus is a deep stabilizing muscle in the lower back that helps support the lumbar spine during everyday movement. When this muscle becomes inhibited after injury, the spine may lose automatic support — creating a cycle of pain, instability, guarding, and frustration.

We also explore how ReActiv8® restorative neurostimulation is different from traditional spinal cord stimulation. Instead of masking pain signals, ReActiv8® is designed to activate the motor nerve that controls the multifidus muscle, helping restore neuromuscular control over time.

In this episode, we discuss:

✅ Why chronic low back pain can persist even after other treatments

✅ What the multifidus muscle does

✅ How multifidus dysfunction can contribute to mechanical low back pain

✅ Why physical therapy may not fully correct reflexive muscle inhibition

✅ What arthrogenic muscle inhibition means

✅ How ReActiv8® restorative neurostimulation works

✅ How ReActiv8® differs from spinal cord stimulation

✅ What patients may feel during therapy sessions

✅ Why improvement can take months

✅ Who may be a candidate for ReActiv8®

This conversation also explains why ReActiv8® is not intended for every type of back pain. It is generally considered for carefully selected patients with chronic mechanical, axial low back pain who have tried conservative care without enough relief and do not have a clear surgical problem that needs correction.

At Vertrae® in Dayton, Ohio, Dr. Kamal Woods personally evaluates patients to determine whether multifidus dysfunction may be contributing to their chronic low back pain and whether ReActiv8® may be appropriate.

Learn more or request an evaluation at Vertrae.com

#ReActiv8 #RestorativeNeurostimulation #ChronicLowBackPain #Multifidus #MultifidusDysfunction #MechanicalBackPain #LowBackPain #BackPainRelief #SpineCare #Neuromodulation #Neurosurgery #DaytonOhio #Vertrae #DrKamalWoods

What if you could test drive a major spine treatment before making a permanent decision?

In this episode, we take a deep dive into the spinal cord stimulation trial — one of the most patient-centered parts of the SCS process. For patients living with chronic nerve pain, the trial offers something unusual in medicine: the chance to test the therapy in real life before deciding whether to move forward with a permanent implant.

We explore why the SCS trial is different from both spine surgery and temporary injections. Unlike a fusion or laminectomy, the trial does not permanently change the structure of the spine. Unlike an injection, it is not simply a medication that wears off. Instead, temporary leads are placed in the epidural space near the spinal cord and connected to an external generator, allowing patients to experience the therapy during daily activities.

In this episode, we discuss:

✅ What a spinal cord stimulation trial is

✅ How the SCS trial works in real life

✅ Why the trial is not the same as surgery

✅ What the epidural space actually means

✅ How SCS may help modulate nerve pain signals

✅ Why sleep, function, and movement matter during the trial

✅ What doctors look for besides pain scores

✅ What happens if the trial gives partial relief

✅ Why a non-response can still provide valuable information

✅ How the trial gives patients more control over the decision

The goal of the SCS trial is not just to ask, “Did your pain score improve?” It is to ask: could you sleep better, sit longer, walk farther, move more freely, or do something during the trial week that pain had previously taken away?

At Vertrae® in Dayton, Ohio, the SCS trial is part of a stepwise, reversible process designed to help patients make an informed decision based on their own lived experience — not just statistics or someone else’s outcome.

If chronic nerve pain has been limiting your sleep, movement, independence, or quality of life, a spinal cord stimulation evaluation may help determine whether SCS is the right fit for your pain pattern.

Learn more at Vertrae.com

#SpinalCordStimulation #SCSTrial #SpinalCordStimulator #ChronicPain #NervePain #NeuropathicPain #PainManagement #SpineCare #Neuromodulation #BackPain #LegPain #DaytonOhio #Vertrae #PatientCenteredCare

Is spinal cord stimulation (SCS) really a last resort, or could it be the right tool for the right type of chronic pain?

In this episode, we take a deep dive into the most common questions patients ask before an SCS evaluation, using insights from Vertrae® in Dayton, Ohio. This conversation explores how spinal cord stimulation works, what neuropathic pain feels like, what patients can expect during the temporary SCS trial, and why this therapy is considered reversible.

We also discuss the difference between mechanical back pain and neuropathic nerve pain, including symptoms like burning, shooting, electric, or radiating pain that may travel down the leg or persist even at rest. For patients with persistent nerve pain after spine surgery, complex regional pain syndrome, or painful diabetic neuropathy, SCS may be part of a thoughtful treatment conversation.

In this episode, you’ll learn:

✅ What spinal cord stimulation is

✅ Whether SCS is a “last resort”

✅ How neuropathic pain differs from mechanical pain

✅ What the temporary SCS trial involves

✅ What an implanted spinal cord stimulator feels like

✅ Whether an SCS system can be removed

✅ How newer high-frequency and closed-loop systems work

✅ When another back surgery may or may not be the right option

Unlike structural spine surgery, spinal cord stimulation does not remove arthritis, repair a disc, or fuse the spine. Instead, it uses gentle electrical signals to help change how the nervous system processes pain. And because patients typically complete a temporary trial first, they can test the therapy before deciding whether to move forward with a permanent implant.

If you are living with chronic nerve pain, shooting leg pain, persistent pain after back surgery, or symptoms that have not improved with conservative care, an SCS evaluation may help determine whether this treatment is right for you.

To learn more or schedule an evaluation, visit Vertrae.com.

#SpinalCordStimulation #SCS #ChronicPain #NervePain #NeuropathicPain #BackPain #LegPain #PainManagement #SpineCare #Neuromodulation #PersistentSpinalPain #FailedBackSurgerySyndrome #CRPS #DiabeticNeuropathy #Vertrae #DaytonOhio